Measurement of Patient Reported Gastrointestinal (GI) and Health-Related Quality of Life (HRQL) Outcomes in Renal Transplant Recipients (MyLife).
Phase of Trial: Phase IV
Latest Information Update: 20 Oct 2009
At a glance
- Drugs Mycophenolate sodium (Primary)
- Indications Renal transplant rejection
- Focus Adverse reactions
- Sponsors Novartis
- 20 Oct 2009 Actual end date (Jan 2007) and actual number of patients (196) added as reported by ClinicalTrials.gov.
- 20 Oct 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 06 Dec 2005 New trial record.